Salute e Benessere

Eureka Unveils the E20 Plus with Advanced Cleaning Performance and Obstacle…

The Eureka E20 Plus continues the innovative design of the E10s. Unlike traditional robotic vacuums with base stations, the Eureka E20 Plus features a bag-free base station. After cleaning, the base station collects debris in a dust cup, much like most cordless vacuums. When the dust cup is full, press a button to empty it, and users are ready for the next cleaning session, saving both money and time. The Eureka E20 Plus continues the innovative design of the E10s. Unlike traditional robotic...
PR Newswire
30/08/2024

Trading by management and close relations of management

Please read the full announcement in PDFAttachment 2024_29_Trading_By_Management
Nasdaq GlobeNewswire
30/08/2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 30 August 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
30/08/2024

Ibuprofen Market to Reach $213.6 Million, Globally, by 2033 at 7.9% CAGR: Allied…

The global ibuprofen market is experiencing growth due to widespread adoption of the nonsteroidal anti-inflammatory drug such as ibuprofen for pain management, rise in geriatric population, and surge in prevalence of chronic disease. Furthermore, the availability of over-the-counter ibuprofen is expected to further increase the adoption of ibuprofen among its users. The global ibuprofen market is experiencing growth due to widespread adoption of the nonsteroidal anti-inflammatory drug such as...
PR Newswire
30/08/2024

ZINZINO AB (PUBL): INTERIM REPORT SECOND QUARTER 2024

Revenues in the second quarter of 2024 amounted to SEK 507.0 (407.9) million, corresponding to 24% (24%) growth compared to the corresponding period last year. EBITDA increased to SEK 63.0 (53.7) million, and the EBITDA margin amounted to 12.4% (13.2%). During the quarter, Zinzino acquired the rights to Luxembourg-based Xelliss SA distributor database, inventory and IP assets, acquired 49% of the shares in the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD and signed a letter of intent to…
PR Newswire
30/08/2024

Global Vaccine Adjuvants Market to Show Remarkable Growth at a CAGR of ~13% by…

Key Takeaways from the Vaccine Adjuvants Market Report Key Takeaways from the Vaccine Adjuvants Market Report To read more about the latest highlights related to the vaccine adjuvants market, get a snapshot of the key highlights entailed in the Global Vaccine Adjuvants Market Report Vaccine Adjuvants Overview Vaccine adjuvants are substances added to vaccines to enhance the body's immune response to the primary antigen. By stimulating the immune system more effectively,...
PR Newswire
29/08/2024

Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options

Each Unit is comprised of: (i) one (1) common share in the capital of the Company (each a "Common Share"); and (ii) one (1) common share purchase warrant (each a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share at a price ofC$0.32for a period of four (4) years from the date of issuance. Innocan intends to use the proceeds of the Offering for working capital and general corporate purposes. The securities issued to Canadian subscribers…
PR Newswire
29/08/2024

EssilorLuxottica: successful Euro 2 billion bond issuance at 2.99%

NOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS PRESS RELEASE This press release does not constitute a solicitation nor an offer to purchase the Bonds (as such term is defined below) in the United States of America or to, or for the account or benefit of, U.S. Persons (as defined in Regulation S under the US...
Nasdaq GlobeNewswire
29/08/2024

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…

Disclosure of Share Capital and Voting Rights Outstandingas of July 31, 2024(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Charenton-le-Pont, France (August 29, 2024 - 6:00 pm)– As of July 31, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks...
Nasdaq GlobeNewswire
29/08/2024

RAMSAY SANTE : Provisional annual results at the end of June 2024

PRESS RELEASE Paris, 29 thAugust 2024 Provisional annual results at the end of June 2024As a mission-driven company, Ramsay Santé, thanks to its employees and medical community, is committed to expanding its pioneering role in access to care and medical innovation benefiting 12.6 million patients in France, the 3 Nordics countries and Italy.Ramsay Santé has further implemented its “Yes We Care 2025” unique and differentiating strategy to offer integrated care to...
Nasdaq GlobeNewswire
29/08/2024

Gastrointestinal Products Market worth $19.7 billion in 2029 driven by…

Browse in-depth TOC on "Gastrointestinal Products Market"145 - Tables55 - Figures350 - Pages Browse in-depth TOC on "Gastrointestinal Products Market" 145 - Tables 55 - Figures 350 - Pages Boston Scientific: Innovator in Gastroenterology Devices Boston Scientific (U.S.) is a leading player in the gastroenterology market, offering a wide range of innovative products for diagnosing and treating gastrointestinal disorders. Key offerings include the SpyGlass DS Direct...
PR Newswire
29/08/2024

Digital Radiography Market worth $1.9 billion by 2029 driven by Emerging Tech…

Browse in-depth TOC on "Digital Radiography Market" Browse in-depth TOC on "Digital Radiography Market" 204 - Tables 54 - Figures 222 - Pages Siemens Healthineers: Leader in Digital Radiography Innovation Siemens Healthineers ( Germany ) is a global leader in medical technologies, particularly in digital radiography systems. These systems combine cutting-edge technology with advanced imaging capabilities to deliver high-quality diagnostic images while prioritizing patient...
PR Newswire
29/08/2024

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per August 27, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,989,390 shares, corresponding to 5.12% (previously 4.99%) of the total share capital attached to shares. The combined total of share...
Nasdaq GlobeNewswire
29/08/2024

Sobi has completed issues of class C shares

On 15 July 2024, the Board of Directors of Sobi resolved to, conditional upon subscription and payment from Svenska Handelsbanken AB, repurchase all issued class C shares. Svenska Handelsbanken AB has today subscribed for all 1,641,103 issued class C shares and the new share issues are therefore completed. The total proceeds from the issues amount to SEK 900,482.19 and have been paid on this day. On15 July 2024, the Board of Directors of Sobi resolved to, conditional upon subscription and...
PR Newswire
29/08/2024

EXPANSE MEDICAL WELCOMES JEFF HOPKINS AS CEO AND BOARD MEMBER OF ITS SPIN-OFF…

"We are thrilled to welcome Jeff to the team," said Eitan Konstantino, founder of Expanse Medical. "His visionary leadership and deep commercialization expertise make him the ideal leader for our company through this exciting phase of growth. We are confident that under his guidance, FlowPhysix will set new standards in thrombectomy and improve patient outcomes worldwide." In his new role, Mr. Hopkins will build a world class commercial organization and position FlowPhysix's…
PR Newswire
29/08/2024

UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics

The financial and legal due diligence on Bowen Therapeutics is a critical step necessary for UTime to secure its investment and build a solid foundation of information to support its acquisition decision. The due diligence process will cover a wide range of aspects of Bowen Therapeutics's business and operations and involve in-depth investigations and analysis. Specifically, in terms of financial due diligence, UTime will focus on Bowen Therapeutics's financial statements, assets and…
PR Newswire
29/08/2024

ZEISS innovation paves way to more personalized patient care with cutting-edge…

NEW DIGITAL & SURGICAL ENHANCEMENTS IN THE OR: Expanded portfolio of advanced optical and digital ophthalmic microscopes introduced in CE markets with ZEISS ARTEVO 750 and ZEISS ARTEVO 850. NEW DIGITAL & SURGICAL ENHANCEMENTS IN THE OR: Expanded portfolio of advanced optical and digital ophthalmic microscopes introduced in CE markets with ZEISS ARTEVO 750 and ZEISS ARTEVO 850. EXCELLENT IOL CLINICAL RESULTS: ZEISS showcases its advanced ZEISS IOL portfolio, including new clinical...
PR Newswire
29/08/2024

The Future of Smartphone Design Is Here: Infinix and WGSN Reveal 2025 Smartphone…

The Infinix x WGSN 2025 Trend Report features six key forces—"STEPIC Drivers"—that will shape global economic, technological, environmental, and cultural development. These macro forces are set to play a pivotal role in the global economy and business landscape by 2025 and beyond. The report identifies significant global trends, from political instability and economic uncertainty to the decentralization of digital culture, migration waves, the rise of the space economy, and the…
PR Newswire
29/08/2024

Omega-3 Market to Reach $30.8 Billion, Globally, by 2033 at 14.7% CAGR: Allied…

Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A01355 Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A01355 Prime determinants of growth The omega-3 market has experienced robust growth driven by several key factors. Firstly, rising consumer awareness of the health benefits associated with omega-3 fatty acids, such as their role in supporting cardiovascular health, cognitive function, and overall well-being, has significantly...
PR Newswire
29/08/2024

Augere Medical Secures MDR CE-mark for its PolypAId™ Software and System

David Borge Larsen, Augere's interim CEO, commented: "This regulatory approval for PolypAId™ is a major milestone for Augere and we have been working hard to achieving the MDR CE-mark over the last years. We are excited to start the commercialization of PolypAId™, working with clinicians and healthcare providers to augment screening of colorectal cancer and in general to increase prevention of bowel cancer and thereby improving patient care." David Borge Larsen, Augere's interim…
PR Newswire
29/08/2024

Medicilon Expands Global Presence with Official Opening of Second R&D Center in…

Medicilon aims to enhance its contribution to pharmaceutical innovation by harnessing the proximity to numerous top biotech companies and research institutions. The Lexington site provides critical research services, while ensuring smooth communication with both industry-based and academic drug development teams. Medicilon's commitment to quality and innovation will keep its research partners competitive as new therapeutic technologies continue to emerge. Medicilon aims to enhance its...
PR Newswire
29/08/2024

KFSHRC Concludes Participation at AMEE 2024 in Switzerland

BASEL, Switzerland, Aug.29, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) successfully concluded its participation in the Association for Medical Education in Europe (AMEE) 2024 Conference, which commenced last Monday in Basel, Switzerland. The three-day event provided a platform for KFSHRC to showcase its expertise in employing the latest technologies in medical education, including virtual simulation and interactive learning tools, to a global...
Nasdaq GlobeNewswire
29/08/2024

Raytron Boosts Global Infrared Imaging Technology Across 15 Years' Innovation

Dr. Lee, a senior engineer at Raytron, shares the company's forward-thinking vision: "At Raytron, we don't just think about technology in terms of specific industries; we see it as a powerful tool for broader societal progress." He explains how this vision is realized in various fields, such as healthcare, where Raytron's 12μm 1280 resolution infrared thermal imaging product has helped complex brain surgeries by enabling surgeons to work with greater precision and achieve better…
PR Newswire
29/08/2024

Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to…

Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025, once approved by the U.S. FDA. The U.S. FDA has accepted the Company's Biologics License Application (BLA) for Bmab 1200 (bUstekinumab) for review under the 351(k) pathway. Biocon Biologics earlierannounced a settlement agreement inthe United States for a Bmab 1200 launch no later thanFebruary 22, 2025, once approved by the U.S. FDA. The U.S. FDA has...
PR Newswire
29/08/2024
Altri  Comunicati